Breaking News Instant updates and real-time market news.

CAPR

Capricor Therapeutics

$0.68

0.0049 (0.72%)

08:07
07/18/17
07/18
08:07
07/18/17
08:07

Capricor Therapeutics: FDA grants Rare Pediatric Disease Designation to CAP-1002

Capricor Therapeutics announced that the U.S. FDA has granted Rare Pediatric Disease Designation to CAP-1002, Capricor's development candidate for the treatment of Duchenne muscular dystrophy, a debilitating genetic disorder characterized by progressive weakness and chronic inflammation of skeletal, heart, and respiratory muscles. The Rare Pediatric Disease Designation, as well as the Orphan Drug Designation previously granted to CAP-1002 by the FDA, covers the broad treatment of DMD. Upon receiving market approval for CAP-1002 by the FDA, Capricor would be eligible to receive a Priority Review Voucher. In April 2017, Capricor announced positive results from its Phase I/II HOPE clinical trial of CAP-1002 in DMD patients with advanced disease. The company recently met with the FDA to discuss potential product registration strategies for this indication, and Capricor plans to commence a randomized, double-blind, placebo-controlled clinical trial of intravenous, repeat-dose CAP-1002 in boys and young men with Duchenne in the second half of this year, subject to regulatory approval. Capricor expects to report 12-month results from the HOPE Trial in the fourth quarter of 2017.

CAPR Capricor Therapeutics
$0.68

0.0049 (0.72%)

02/13/17
RODM
02/13/17
INITIATION
Target $14
RODM
Buy
Capricor Therapeutics assumed with a Buy at Rodman & Renshaw
Rodman & Renshaw analyst Joseph Pantginis assumed coverage of Capricor Therapeutics with a Buy rating and $14 price target. The analyst believes the company has the potential to be a leader in cardiovascular regenerative medicine.

TODAY'S FREE FLY STORIES

IBM

IBM

$146.40

-0.4 (-0.27%)

16:13
10/17/17
10/17
16:13
10/17/17
16:13
Earnings
IBM backs FY17 adjusted EPS view of at least $13.80, consensus $13.75 »

Operating diluted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

IBM

IBM

$146.43

-0.37 (-0.25%)

16:13
10/17/17
10/17
16:13
10/17/17
16:13
Hot Stocks
IBM reports Q3 cloud revenues up 20% to $4.1B »

Third-quarter cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

IBM

IBM

$146.45

-0.35 (-0.24%)

16:12
10/17/17
10/17
16:12
10/17/17
16:12
Earnings
IBM reports Q3 adjusted EPS $3.30, consensus $3.28 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

COTY

Coty

$16.01

-0.82 (-4.87%)

16:12
10/17/17
10/17
16:12
10/17/17
16:12
Initiation
Coty initiated  »

Coty initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRS

Northern Trust

$91.10

-0.82 (-0.89%)

16:11
10/17/17
10/17
16:11
10/17/17
16:11
Hot Stocks
Northern Trust CEO Frederick Waddell to step down »

Northern Trust announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

LRCX

Lam Research

$194.55

2.19 (1.14%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Earnings
Lam Research sees Q2 EPS $3.65, +/- 12c, consensus $3.33 »

Sees Q2 revenue $2.55B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CREE

Cree

$29.34

0.06 (0.20%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Earnings
Cree sees Q2 adjusted EPS (1c)-4c, consensus 7c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PTX

Pernix Therapeutics

$2.76

-0.05 (-1.78%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Hot Stocks
Pernix Therapeutics CFO Graham Miao to resign at the end of the year »

Pernix Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUSA

Houston American Energy

$0.43

-0.0128 (-2.88%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Syndicate
Breaking Syndicate news story on Houston American Energy »

Houston American Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Technical Analysis
Technical View: Select Comfort drops after earnings miss »

In the extended session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Earnings
MobileIron sees Q3 revenue $42M-$43M, consensus $45.22M »

Sees Q3: Gross billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCSG

Healthcare Services

$54.37

-0.08 (-0.15%)

16:08
10/17/17
10/17
16:08
10/17/17
16:08
Hot Stocks
Healthcare Services increases dividend to 19c per share »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

16:08
10/17/17
10/17
16:08
10/17/17
16:08
Hot Stocks
MobileIron CEO Barry Mainz to leave, Simon Biddiscombe to succeed »

MobileIron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHEF

Chefs' Warehouse

$20.75

0.2 (0.97%)

16:07
10/17/17
10/17
16:07
10/17/17
16:07
Hot Stocks
Chefs' Warehouse announces resignation of CFO John Austin »

The Chefs' Warehouse…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

16:07
10/17/17
10/17
16:07
10/17/17
16:07
Earnings
Select Comfort narrows FY17 EPS view to $1.30-$1.45 from $1.25-$1.50 »

Consensus $1.39. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

LRCX

Lam Research

$194.32

1.95 (1.01%)

16:07
10/17/17
10/17
16:07
10/17/17
16:07
Earnings
Lam Research reports Q1 EPS $3.46, consensus $3.28 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

16:06
10/17/17
10/17
16:06
10/17/17
16:06
Hot Stocks
Select Comfort increases share repurchase authorization to $500M »

Select Comfort announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HCSG

Healthcare Services

$54.37

-0.08 (-0.15%)

16:06
10/17/17
10/17
16:06
10/17/17
16:06
Earnings
Healthcare Services reports Q3 EPS 31c, consensus 31c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CP

Canadian Pacific

$167.09

-1.375 (-0.82%)

16:06
10/17/17
10/17
16:06
10/17/17
16:06
Earnings
Canadian Pacific sees FY17 EPS to grow in double-digits from prior year »

CP is revising its 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SNPS

Synopsys

$83.72

-0.35 (-0.42%)

16:06
10/17/17
10/17
16:06
10/17/17
16:06
Hot Stocks
Synopsys acquires Sidense Corporation, terms not disclosed »

Synopsys announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

16:06
10/17/17
10/17
16:06
10/17/17
16:06
Earnings
Select Comfort reports Q3 EPS 62c, consensus 68c »

Reports Q3 revenue $403M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CREE

Cree

$29.34

0.06 (0.20%)

16:04
10/17/17
10/17
16:04
10/17/17
16:04
Earnings
Cree reports Q1 EPS 4c, consensus 4c »

Reports Q1 revenue $360M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CP

Canadian Pacific

$167.06

-1.4 (-0.83%)

16:04
10/17/17
10/17
16:04
10/17/17
16:04
Hot Stocks
Canadian Pacific reports operating ratio 56.7% »

On the strength of its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HAFC

Hanmi Financial

$30.80

-0.4 (-1.28%)

16:03
10/17/17
10/17
16:03
10/17/17
16:03
Earnings
Breaking Earnings news story on Hanmi Financial »

Hanmi Financial reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 09

    Nov

MSG

Madison Square Garden

$214.97

-2.785 (-1.28%)

, MSGN

MSG Networks

$20.88

0.125 (0.60%)

16:03
10/17/17
10/17
16:03
10/17/17
16:03
Hot Stocks
Madison Square Garden and MSG Networks renew and expand Delta partnership »

Madison Square Garden…

MSG

Madison Square Garden

$214.97

-2.785 (-1.28%)

MSGN

MSG Networks

$20.88

0.125 (0.60%)

DAL

Delta Air Lines

$52.77

-0.8515 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.